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1. Introduction
  Bacterial meningitis results from the invasion of the 
cerebrospinal fluid by bacteria[1]. It can extend to an infection
of the lining surrounding the brain. Neisseria meningitides
(N. meningitides) is a major cause of acute meningitis, 
followed by Streptococcus pneumoniae (S. pneumoniae) and 
Haemophilus influenzae (H. influenzae)[2-4]. By their high 
infectivity, they can cause epidemics of cerebrospinal 
meningitis and septicemia[5]. According to the world health 
organization, meningococcal infections are endemic in the 
world, with 50 000 cases per year[6]. The annual incidence of 
the meningococcal disease is estimated to 1 to 5 cases per 
100 000 people in industrialized countries, with a seasonal 
increase between November and May[7]. Other species 
commonly found in these infections are staphylococci and 
some enterobacteria, with Escherichia coli (E. coli) as the 
leading agent.
  In all cases, the mortality rate is around 10%[6]. In the 
absence of any treatment, 5% to 10% of patients die within 
24 hours of onset of symptoms and from 10% to 20% of 
those who survive present severe neurological sequels such 
as hearing loss and learning disabilities[8,9].
Objective: To assess the seasonality of the bacterial meningitis and the antibiotic resistance of 
incriminated bacteria over the last three years in the northern Togo. Methods: From January 
2007 to January 2010, 533 cerebrospinal fluids (CSF) samples were collected from patients 
suspected of meningitis in the Regional Hospital of Dapaong (northern Togo). After microscopic 
examination, samples were cultured for bacterial identification and antibiotic susceptibility. 
Results: The study included 533 patients (306 male and 227 female) aged from 1 day to 55 years 
[average age (13.00依2.07) years]. Bacterial isolation and identification were attempted for 254/533 
(47.65%) samples. The bacterial species identified were: Neisseria meningitidis A (N. meningitidis 
A) (58.27%), Neisseria meningitidis W135 (N. meningitidis W135) (7.09%), Streptococcus 
pneumoniae (S. pneumoniae) (26.77%), Haemophilus influenza B (H. influenza B) (6.30%) and 
Enterobacteriaceae (1.57%). The results indicated that bacterial meningitis occur from November 
to May with a peak in February for H. influenzae and S. pneumoniae and March for Neisseriaceae. 
The distribution of positive CSF with regards to the age showed that subjects between 6 and 
12 years followed by subjects of 0 to 5 years were most affected with respective frequencies 
of 67.82% and 56.52% (P<0.001). Susceptibility tests revealed that bacteria have developed 
resistance to several antibiotics including aminosides (resistance rate >20% for both bacterial 
strains), macrolides (resistance rate > 30% for H. influenzae) quinolones (resistance rate >15% 
for H. influenzae and N. meningitidis W135). Over three years, the prevalence of S. pneumoniae 
significantly increased from 8.48% to 73.33% (P<0.001), while the changes in the prevalence 
of H. influenzae B were not statistically significant: 4.24%, vs. 8.89%, (P= 0.233). Conclusions: 
Our results indicate that data in African countries differ depending on geographical location 
in relation to the African meningitis belt. This underlines the importance of epidemiological 
surveillance of bacterial meningitis.
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  For decades, Africa is the continent most affected by 
epidemics of meningococcal meningitis, with an area called 
“African meningitis belt” that spans from the entire width 
of the west coast to Sudan and some parts of Ethiopia. The 
mortality is generally high and is around 13%. The epidemic 
that occurred in 1996-1997 was particularly devastating. In 
10 months, there were 149 166 cases of meningitis and 15 750
deaths in the 22 countries in the African meningitis belt. 
Benin, Burkina Faso, Gambia, Ghana, Mali, Niger and Togo 
were particularly affected[10,11].
  In Togo, the Savannah region in the north is the area most 
affected. During the epidemic of the year 1996-1997, it 
recorded 90% of cases of meningitis and 89% of deaths in 
the country. However, no current data on the prevalence of 
bacteria implicated in meningitis infections is available. 
The present study was conducted to assess the prevalence of 
bacteria implicated in meningitis and their susceptibility to 
antibiotics in Dapaong, northern Togo.
2. Materials and methods
2.1. Patients and pathological products
  This study is a retrospective study that covered the period 
from January 2007 to January 2010 at the Regional Hospital 
of Dapaong (RHD) in Savannah Region, northern Togo. The 
Savannah Region is one of the five health regions of the 
country. It is located in the far north and borders with the 
three neighboring countries of Togo: Burkina Faso to the 
north, Ghana to the west and Benin to the east. To the south, 
it is bordered with the region of Kara. The capital of the 
region is the city of Dapaong that has the regional hospital. 
This is the referral health centre in the region. 
  This study involved 533 patients including 306 male and 
227 female with sex ratio of 1.35. Patients ranged in age 
from 1 day to 55 years with a mean age of (13.00依2.07) years. 
Patients were divided into five age groups: 0 to 5 years, 6-12 
years, 13-19 years, 20-39 years and from 40 to 55 years 
with as respective effectives 199, 138, 87, 80 and 29. The 
study population was admitted to the RHD with suspected 
cerebrospinal infection. Cerebrospinal fluid (CSF) was 
collected from each patient by lumbar puncture.
2.2. Bacteriological techniques
  All culture media and antibiotics disks used in this study 
were provided by BioRad (France). Each CSF was analyzed 
for the appearance, the quantitative cytology, the gram 
staining and the bacterial identification and the isolation 
followed by the antimicrobial susceptibility testing.
  The macroscopic study of CSF was made by direct 
observation. The quantitative cytology consisted of an 
enumeration of white blood cells of the CSF using Nageotte 
cell. The bacterial growth and the isolation were assayed by 
inoculating chocolate agar+PolyViteX or blood agar. Cultures 
were incubated at 37 曟 under CO2 atmosphere. Negative 
samples were those for which no colonies were observed 
after 72 h of incubation. The identification of bacteria was 
made by the conventional methods used in the center. The 
susceptibility testing was performed on Muller Hinton agar 
following the recommendations of the French Society for 
Microbiology[12].
2.3. Data analysis
  Data were recorded with SPSS-12 software for calculation 
of frequencies. The Fisher test by calculation of 氈
2 values 
was used to compare frequencies with the software Epi-Info 
version 6.04. The significance level was set at P <0.05.
3. Results
3.1. Macroscopic appearance and quantitative cytology of 
CSF
  Of the 533 CSF samples analyzed, the bacterial growth 
and the identification were attempted for 254, showing a 
positivity rate of 47.65%. The search for bacterial pathogens 
was negative for the other samples. Of the 254 positive 
samples, 150 were from males while 104 were from female 
subjects. Statistical analysis by the 氈
2 test revealed that the 
positivity of the CSF was not related to the sex of the patient 
(P = 0.460).
  Table 1 shows the macroscopic appearance of the positive 
samples. Data in the table reveal that the majority of CSF 
246 (96.86%) had a cloudy appearance. Two samples (0.78%) 
were bloody, while one sample (0.39%) presented a normal 
appearance (crystal clear). Other five samples (1.97%) were 
purulent. Similarly quantitative cytology of CSF showed that 
215 (84.65%) samples had more than 1 000 leucocytes per mm3,
35 (13.78%) had between 10 and 1 000 leucocytes per mm3 
and 4 (1.57%) samples had less than 10 leucocytes per mm3.
Indeed 98.43% had abnormal cytology, constituted of 
polynuclear cells essentially.
 
3.2. Distribution of bacteria isolated from CSF 
  The gram staining revealed the presence of bacterial 
pathogens in 260 samples. This was confirmed by the 
cultivation of the samples. Thus 260 bacterial strains 
were isolated from the CSF and distributed as follows: 148 
(56.93%) N. meningitidis A, 18 (6.93%) N. meningitidis W135, 
68 (21.15%) Streptococcus pneumoniae (S. pneumoniae), 16 
(6.15%) Haemophilus influenza B (H. influenza B) and 10 
(3.84%) enterobacteria. The number of isolates per year was 
165, 50 and 45 respectively for 2007-2008, 2008-2009 and 
2009-2010. Figure 1 shows the proportion of each species 
per year. N. meningitidis A was the most isolated bacterial 
species during the first year of the study, and its prevalence 
significantly decreased from 76.36% to 8.86% through 
36% (P <0.001). N. meningitidis W135 was not isolated 
during the final year of the study, but its prevalence did 
not significantly change during the first two years of the 
study (8.48% and 8.00%, respectively with P = 0.858). The 
prevalence of S. pneumoniae significantly increased in three 
years from 8.48% to 73.33% (P<0.001). The prevalence of 
H. influenzae B was 4.24%, 10.00% and 8.89% for the three 
years but the changes were not statistically significant (P = 
0.233).
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Figure 1. Distribution of bacterial strains during three years in 
Dapaong.
  Figure 2 shows the seasonal distribution of bacterial 
strains. It appears in the figure that no species was isolated 
between April and October. The period of isolation has two 
major peaks according to the categories of bacteria. Thus, 
March is the period of high prevalence of Neisseriaceae i.e. 
N. meningitidis A and N. meningitidis W135; 80% and 
60% of these species were isolated during this month 
respectively. For S. pneumoniae and H. influenzae B, 
February is the peak of isolation, 36% and 31% of strains 
of S. pneumoniae and H. influenzae B, respectively, were 
isolated during this month.
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Figure 2. Seasonal distribution of bacterial strains in Dapaong.
  The distribution of positive CSF samples according to age 
groups is presented in Table 1. The overall distribution 
shows a very significant difference between age groups 
(P<0.001). The persons between 13 and 19 years were the 
most affected with a frequency of 67.82%, followed by the 
persons in the range of 6-12 years, 0-5 years and 20-39 
years with frequencies of 56.52%, 40.20% and 40.00%. 
respectively. However statistical analysis revealed that there 
was no significant difference between the age of 0-5 years 
and 20-39 years (P = 0.975). With regard to the distribution 
of bacterial species according to the age of patients, it 
appears that Neisseriaceae and H. influenzae B did not 
infect patients over 40 years. Only S. pneumoniae was found 
in all age groups with statistically different prevalence (P = 
0.011). This bacterium mostly affected patients over 40 years 
with a prevalence of 31.03% in this age group. H. influenzae 
B was found only in people under the 5 years and subjects 
aged from 6 to 12 years, with a higher prevalence in patients 
under 5 years (7.04% versus 1.45%, P=0.017).
3.3. Antibiotic susceptibility of the bacterial strains
  Seven families of antibiotics were tested on the isolated 
strains as shown in Table 2. The results revealed that
N. meningitidis W135 presented the most resistant strains 
to antibiotics. Thus, over 75% of strains resisted to 
trimethoprime and amikacin. For this species sensitivity 
was uniform (12.50%) to beta lactam antibiotics.
N. meningitidis A presented a resistance profile similar to 
N. meningitidis W135. The highest resistance rates were 
recorded with trimethoprime, amikacin and tobramicin. 
For this bacterial species quinolones i.e. ciprofloxacin, 
ofloxacin and norfloxacin seemed to be the most active, with 
resistance rates around 10%. In contrast, macrolides i.e. 
erythromycin, lincomycin and prystinamicin with resistance 
rates below 10% were the most active on N. meningitidis 
W135. With S. pneumoniae resistance rates were relatively 
low. The highest resistance rates were slightly above 25% 
for aminoglycosides. No resistance was recorded with 
certain antibiotics such as lincomycin, prystinamicin and 
doxycycline. With H. influenzae B, no resistance has been 
recorded with cephalosporins, but noticeable resistance 
was recorded against antibiotics such as amikacin and 
pristianamycin. Resistance rates of 46.16% and 35.72% were 
recorded for these antibiotics respectively.
4. Discussion 
  This study is a retrospective study that aimed to assess 
the epidemiological and evolutionary aspects of bacterial 
meningitis in the savannah region in northern Togo. The 
study has confirmed 254 cases of bacterial meningitis in 533 
suspected subjects, including 148 cases of meningitis caused 
by N. meningitidis A, 18 cases caused by N. meningitidis 
W135, 68 cases by S. pneumoniae, 16 cases by H. influenza B 
and 10 cases due the enterobacteria. These results show that 
overall, Neisseriaceae were the leading cause of bacterial 
meningitis in the savannah region in Togo in the three 
past years. Several studies have reported the prevalence of
N. meningitidis in cerebrospinal infections[11,13]. Levy et al 
Table 1
Distribution of positive CSF and bacterial strains in relation with the age of the patients.
Strain 0-5 years (n=199) 6-12 years(n=138) 13-19 years(n=87) 20-39 years(n=80)  40-55 years (n=29) P 
Positive CSF 40.20  56.52  67.82 40.00 31.03 <0.001a
N. meningitidis A 21.60 34.06 41.38 26.25   0.00   0.003b
N. meningitidis W135   2.01   3.62   4.60   3.75   0.00   0.653b
S. pneumoniae   9.05 15.94 12.64 10.00 31.03   0.011a
H. influenzae B   7.04   1.45   0.00   0.00   0.00   0.017c
a: P value by 氈
2 test for the 5 age groups, b: P value by  氈
2 test for the 4 first age groups,  c: P value by 氈
2 test for the two first age groups.
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also found that Neisseriaceae were responsible for over half 
of cases of bacterial meningitis in children in France with 
N. meningitidis as the leading species. Serogroups B and 
C were the most encountered; however, these serogroups 
were not found in this study[14]. Our study revealed a rather 
high prevalence of serogroup A (56.93%). Serogroup W 135 
was found in 6.93% cases during the first two years of the 
study. This strain has often been described as responsible for 
outbreak among pilgrims to Mecca and sub Saharan Africa[11].
Our results showed that the incidence of Neisseriaceae 
rise especially in March, which corresponds to a hot dry 
period in the region. The distribution of isolates by year of 
study revealed that the incidence of Neisseriaceae declined 
significantly between 2007 and 2010. Indeed, during 2007, 
a meningitis outbreak was reported in Togo and Burkina 
Faso; this could explain the high prevalence of these 
organisms during the year[10]. However, our results showed 
that, unexpectedly, young people from 13 to 19 were more 
affected than children under 12 years by Neisseriaceae. The 
vaccination campaigns have often been conducted in the 
country but the priority is given to children of preschool and 
school age of 12. This may be a reason but we do not have 
enough data on this coverage. 
  Many studies on the causes of bacterial meningitis have 
often shown a predominance of S. pneumoniae[15]. In a 
study in Cameroon, Fonkoua et al found the prevalence of 
56.2%, 18.5% and 13.4% for S. pneumoniae, H. influenzae 
and N. meningitidis, respectively[13]. S. pneumoniae was 
ranked second after N. meningitidis in our study, this is 
an unexpected, since the first survey in 2000 in the city of 
Lomé located at 600 km in the south of Dapaong showed that
S. pneumoniae followed by H. influenzae and N. meningitidis 
were the main causative agents of bacterial meningitis in the 
following proportions 59.7%, 11.2% and 9.3%, respectively [16].
A second study conducted in 2007 at the national level 
has confirmed the predominance of S. pneumoniae (39%), 
followed by N. meningitidis (35%) and H. influenzae (26%)[17].
This inconsistency with our results could be explained by 
the fact that, Dapaong located in the savannah region in the 
far north of Togo at the border with Burkina Faso is part of 
the African meningitis belt. Our results also showed that S. 
pneumoniae rages on endemosporadic mode with a peak in 
February and affects more adult subjects aged over 40 years. 
Current data do not explain this situation; this study has not 
determined the serogroups of S. pneumoniae to determine 
whether they are covered by the vaccines in the country. 
  H. influenzae B is a major causative agent of bacterial 
meningitis in children in countries where vaccination 
against this bacterium has not been widespread. The current 
impact of meningitis due to H. influenzae in most African 
countries are poorly understood because the statements of 
meningitis are not exhaustive, due to lack of diagnostic and 
inadequate information gathering system[18]. In Togo, data 
on the epidemiology of this agent are scanty. In this study, 
our results showed that the bacterium was ranked third 
behind Neisseriaceae and S. pneumoniae with prevalence 
around 10%, raging in endemosporadic mode with a peak 
in February and affecting preferably children under 5 years. 
However, some authors found no seasonal effect on the 
prevalence of the organism[19]. In this study, the prevalence 
of the organism has not varied significantly over the last three 
years and remains lower than that found in Madagascar[18].
Indeed in that study, the authors have shown that H. influenzae
with an incidence around 32% was the second leading cause 
of bacterial meningitis in children before S. pneumoniae and 
after N. meningitidis.
  We were also interested in the susceptibility of these 
bacteria to antibiotics. The advantage of this aspect of 
the study lies in the fact that without waiting for the 
identification of the agent, an empiric antibiotic therapy 
is often introduced as the presumption diagnosis, taking 
into account the epidemiology of bacteria involved and 
their sensitivity to antibiotics[20-22]. Our results showed that 
Neisseriaceae have developed resistance to all antibiotics 
tested, the lowest rate of resistance is around 8%. For
N. meningitidis A, the lowest rate of resistance was recorded 
with quinolones. Overall, more than 80% of strains were 
sensitive to beta-lactams. These results are similar to those 
of Dagnra et al who reported rates of sensitivity around 83% 
for penicillin G and 100% for cefotaxime[16]. In contrast this 
Table 2
Percentage of resistance strains. 
Antibiotics N. meningitidis W135 N. meningitidis A S. pneumoniae H. influenzae 
Penicillin G 12.50 12.50   7.36   8.75
Ampicillin 12.50 12.50   7.36   8.75
Amoxicillin 12.50 12.50   7.36   8.75 
Cefalotine 16.67 12.50   1.47   0.00
Ceftriaxone 16.67 12.50   1.47   0.00
Cefaloxime 15.28 12.50   1.47   0.00
Gentamicin 23.19 22.22 26.47 30.00
Kanamycin 17.46 22.22 26.47 22.22
Tobramycin 50.00 22.22 26.47 22.22
Amikacin 52.38 77.78 26.47 46.16
Ciprofloxacin 10.25 18.75 11.76 12.50
Ofloxacin   8.70 18.75   8.83 25.00
Norfloxacin   8.70 18.75 - 25.00
Erythromycin -   7.69   5.66 16.66
Lincomycin -   7.69   0.00 33.33
Prystinamin -   7.69   0.00 35.72
Tetracycline - -   6.25 33.33
Doxycyline - -   0.00 33.33
Chloremphenicol 14.86 12.50   2.94 12.50
Trimethroprime 76.10 81.82 11.11 33.33
-  not tested.
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study showed that N. meningitidis was more sensitive to 
chloremphenicol than aminopenicillins. 
  The aminoglycoside antibiotics have been the least efficient 
on S. pneumoniae, and over 25% of strains were resistant 
to these antibiotics. Béré et al in Burkina Faso found that 
over 95% of strains were resistant to amikacin and more 
than 25% were resistant to aminopenicillins[15]. Resistance 
rates recorded with aminopenicillins in this study are below 
the values recorded in Burkina Faso. However these rates 
are similar to those found by Fonkoua et al in Cameroon[13].
The study of Dagnran et al showed that erythromycin was 
more active on S. pneumoniae as chloremphenicol and 
aminopenicillins. Our results showed an opposite situation 
since chloremphenicol was more active than erythromycin 
although the other macrolides showed 100% sensitivity.
  Concerning H. influenzae, beta-lactam antibiotics 
appear to be of choice in the treatment of infections. The 
resistance rate was approximately 8% for penicillins and 
0% for cephalosporins. These results are not consistent 
with those of Dagnran et al who found that chloremphenicol 
and macrolides were more active than beta-lactams on
H. influenzae. However, these results agree well with results 
of studies in Madagascar and Senegal that demonstrated that 
H. influenzae was sensitive to third generation cephalosporins 
but has a high resistance to chloremphenicol[18,23-26]. Other 
studies in Central Africa have shown that aminoglycosides 
were not very effective on H. influenzae but that the activity 
of aminopenicillins was reduced[13,27].
  It appears from this study that, the data in African countries 
differ depending on geographical location in relation to the 
African meningitis belt. This underlines the importance of 
epidemiological surveillance of bacterial meningitis.
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